Disuse induced by botulinum toxin affects the bone marrow expression profile of bone genes leading to a rapid bone loss

Journal of Musculoskeletal Neuronal Interactions

Volumn 13, Issue 1, 2013, Pages 27-36

  Marchand Libouban, Hélène ^a   Le Drevo M A ^a   Chappard, D ^a  

^a UNIV Angers   (France)

Author keywords

Bone Remodeling; Bone Resorption; Botulinum Toxin; Disuse; Gene Expression

Indexed keywords

ALKALINE PHOSPHATASE; BOTULINUM TOXIN; DICKKOPF 1 PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; OSTEOCLAST DIFFERENTIATION FACTOR; SECRETED FRIZZLED RELATED PROTEIN 2; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE INJURY; BONE MARROW; BONE MARROW EXAMINATION; BONE REMODELING; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOLYSIS; QUADRICEPS FEMORIS MUSCLE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIBIA;

ANIMALS; BONE MARROW; BONE RESORPTION; BOTULINUM TOXINS; FEMALE; MICE; MUSCULAR DISORDERS, ATROPHIC; QUADRICEPS MUSCLE; TRANSCRIPTOME;

EID: 84874763113     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Sievanen H. Immobilization and bone structure in humans. Arch Biochem Biophys 2010;503:146-52.
2. Demulder A, Guns M, Ismail A, Wilmet E, Fondu P, Bergmann P. Increased osteoclast-like cells formation in long-term bone marrow cultures from patients with a spinal cord injury. Calcif Tissue Int 1998;63:396-400.
3. Jee WS, Ma Y. Animal models of immobilization osteopenia. Morphologie 1999;83:25-34.
4. Frost HM. The regional acceleratory phenomenon: a review. Henry Ford Hosp Med J 1983;31:3-9.
5. Chappard D, Chennebault A, Moreau M, Legrand E, Audran M, Basle MF. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. Bone 2001;28:72-9.
6. Rossetto O, Morbiato L, Caccin P, Rigoni M, Montecucco C. Presynaptic enzymatic neurotoxins. J Neurochem 2006;97:1534-45.
7. Meunier FA, Schiavo G, Molgo J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 2002;96:105-13.
8. Blouin S, Gallois Y, Moreau MF, Baslé MF, Chappard D. Disuse and orchidectomy have additional effects on bone loss in the aged male rat. Osteoporosis Int 2007;18:85-92.
9. Grimston SK, Goldberg DB, Watkins M, Brodt MD, Silva MJ, Civitelli R. Connexin43 deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis. J Bone Miner Res 2011;26(9):2151-60.
10. Manske SL, Boyd SK, Zernicke RF. Muscle and bone follow similar temporal patterns of recovery from muscleinduced disuse due to botulinum toxin injection. Bone 2010;46:24-31.
11. Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS. Botox induced muscle paralysis rapidly degrades bone. Bone 2006;38:257-64.
12. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54.
13. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002;99:9445-9.
14. Milat F, Ng KW. Is Wnt signalling the final common pathway leading to bone formation? Mol Cell Endocrinol 2009;310:52-62.
15. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D and others. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001;107:513-23.
16. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S and others. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
17. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T and others. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-19.
18. Parfitt AM, Drezner MK, Glorieux FG, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2:595-610.
19. Thomsen JS, Christensen LL, Vegger JB, Nyengaard JR, Bruel A. Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats. Calcif Tissue Int 2012;90:294-306.
20. Poliachik SL, Bain SD, Threet D, Huber P, Gross TS. Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. Bone 2010;46:18-23.
21. Bouvard B, Mabilleau G, Legrand E, Audran M, Chappard D. Micro and macroarchitectural changes at the tibia after botulinum toxin injection in the growing rat. Bone 2012;50:858-64.
22. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 1983; 72:1396-409.
23. Akhter MP, Lappe JM, Davies KM, Recker RR. Transmenopausal changes in the trabecular bone structure. Bone 2007;41:111-6.
24. Kleerekoper M, Villanueva AR, Stanciu J, Sudhaker RD, Parfitt AM. The role of three dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 1985; 37:594-7.
25. Chappard D, Legrand E, Baslé MF, Fromont P, Racineux JL, Rebel A, Audran M. Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 1996;11:676-85.
26. Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 2001;16:97-103.
27. Dempster DW, Arlot MA, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 1983;35:410-7.
28. Frost HM. Some ABCs of skeletal pathophysiology. III: Bone balance and the delta B. BMU. Calcif Tissue Int 1989;45:131-3.
29. Parfitt AM. The mechanism of coupling: a role for the vasculature. Bone 2000;26:319-23.
30. Takata S, Yasui N. Disuse osteoporosis. J Med Invest 2001;48:147-56.
31. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ. Changes in markers of bone formation and resorption in a bed rest model of weightlessness. J Bone Miner Res 1993;8:1433-8.
32. Rantakokko J, Uusitalo H, Jamsa T, Tuukkanen J, Aro HT, Vuorio E. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model. J Bone Miner Res 1999;14:1934-42.
33. Jiang SD, Jiang LS, Dai LY. Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats. Osteoporosis Int 2007;18:339-49.
34. Schett G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011;41:1361-6.
35. Armstrong JW, Balch S, Chapes SK. Interleukin-2 therapy reverses some immunosuppressive effects of skeletal unloading. J Appl Physiol 1994;77:584-9.
36. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M and others. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
37. Ontiveros C, McCabe LR. Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation. J Cell Biochem 2003;88:427-37.
38. Morita S, Nakamura H, Kumei Y, Shimokawa H, Ohya K, Shinomiya K. Hypergravity stimulates osteoblast phenotype expression: a therapeutic hint for disuse bone atrophy. Ann N Y Acad Sci 2004;1030:158-61.
39. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996;2:1132-6.
40. Pfeilschifter J, Wolf O, Naumann A, Minne HW, Mundy GR, Ziegler R. Chemotactic response of osteoblastlike cells to transforming growth factor? J Bone Miner Res 1990;5:825-30.
41. Zhang R, Supowit SC, Hou X, Simmons DJ. Transforming growth factor-beta2 mRNA level in unloaded bone analyzed by quantitative in situ hybridization. Calcif Tissue Int 1999;64:522-526.
42. Raab-Cullen DM, Thiede MA, Petersen DN, Kimmel DB, Recker RR. Mechanical loading stimulates rapid changes in periosteal gene expression. Calcif Tissue Int 1994;55:473-8.
43. nd, Hartmann C, Li L, Hwang TH, Brayton CF and others. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. The Journal of Cell Biology 2002;157:303-14.
44. Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S and others. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 2005;106:3160-5.
45. Jiang SD, Yan J, Jiang LS, Dai LY. Down-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in osteoblasts from rats with chronic spinal cord injury. Joint Bone Spine 2011;78:488-92.
46. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE and others. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. The Journal of Biological Chemistry 2008; 283:5866-5875.
47. Robling AG, Kedlaya R, Ellis SN, Childress PJ, Bidwell JP, Bellido T, Turner CH. Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit boneand envelope-specific attenuation of skeletal effects in Sost-deficient mice. Endocrinology 2011;152:2963-75.
48. Tu X, Rhee Y, Condon KW, Bivi N, Allen MR, Dwyer D, Stolina M, Turner CH, Robling AG, Plotkin LI and others. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 2012;50:209-17.
49. Dehority W, Halloran BP, Bikle DD, Curren T, Kostenuik PJ, Wronski TJ, Shen Y, Rabkin B, Bouraoui A, Morey-Holton E. Bone and hormonal changes induced by skeletal unloading in the mature male rat. Am J Physiol 1999;276:E62-9.